Xuan Qin

9PUBLICATIONS
36CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomaterialsBiologically active moleculesPharmacogenomicsSolution chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 11, 2026
Development of a Second-Generation RARα Selective Antagonist as an Orally Bioavailable, Effective, Safe, and Reversible Male Contraceptive.

|Dec 18, 2025
Metabolism, Pharmacokinetics, and Tissue Distribution of a Selective FK506-Binding Protein 12 F36V Mutant Degrader in Mice.

Shenzhi Zhou, Xuan Qin, Kevin Tran

|Nov 14, 2024
Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology.

Ravikumar Jimmidi, Diana Monsivais, Hai Minh Ta

|Sep 28, 2024
CYP3A-Mediated Carbon-Carbon Bond Cleavages in Drug Metabolism.

Junhui Zhou, Xuan Qin, Shenzhi Zhou

|Sep 18, 2024
Synthesis and Optimization of Small Molecule Inhibitors of Prostate Specific Antigen.

Jeffery A Erickson, Ravikumar Jimmidi, Prashanth Anamthathmakula

|May 23, 2024
Reversible male contraception by targeted inhibition of serine/threonine kinase 33.

Angela F Ku, Kiran L Sharma, Hai Minh Ta

Pageof 2

Frequent Collaborators

6 joint publications

Feng Li

4 joint publications

Srinivas Chamakuri

4 joint publications

Martin M Matzuk

3 joint publications

Kurt M Bohren